Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma
Fox Chase Cancer Center
Fox Chase Cancer Center
University of Texas Southwestern Medical Center
Rutgers, The State University of New Jersey
AIDS Malignancy Consortium
Columbia University
Bristol-Myers Squibb